Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Immunogenicity of intradermal vaccination of Japanese rabies vaccine for preexposure immunization following WHO recommendation.

Yanagisawa N, Takayama N, Mannen K, Nakayama E, Suganuma A.

J Infect Chemother. 2012 Feb;18(1):66-8. doi: 10.1007/s10156-011-0286-2. Epub 2011 Aug 2.

PMID:
21809060
2.

A pilot study on intradermal vaccination of Japanese rabies vaccine for pre-exposure immunization.

Shiota S, Khawplod P, Ahmed K, Mifune K, Nishizono A.

Vaccine. 2008 Nov 25;26(50):6441-4. doi: 10.1016/j.vaccine.2008.08.068. Epub 2008 Sep 18.

PMID:
18804510
3.

Pre-exposure immunization against rabies using Japanese rabies vaccine following the WHO recommended schedule.

Yanagisawa N, Takayama N, Nakayama E, Mannen K, Suganuma A.

J Infect Chemother. 2010 Feb;16(1):38-41. doi: 10.1007/s10156-009-0019-y.

PMID:
20063031
4.

Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.

Madhusudana SN, Sanjay TV, Mahendra BJ, Suja MS.

Int J Infect Dis. 2004 May;8(3):175-9.

5.

A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab).

Ashwathnarayana DH, Madhusudana SN, Sampath G, Sathpathy DM, Mankeshwar R, Ravish HH, Ullas PT, Behra TR, Sudarshan MK, Gangaboraiah, Shamanna M.

Vaccine. 2009 Dec 10;28(1):148-51. doi: 10.1016/j.vaccine.2009.09.090. Epub 2009 Oct 8. Erratum in: Vaccine. 2010 Mar 16;28(13):2575.

PMID:
19818720
6.

Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis.

Wongsaroj P, Udomchaisakul P, Tepsumethanon S, Khawplod P, Tantawichien T.

Vaccine. 2013 Mar 25;31(13):1748-51. doi: 10.1016/j.vaccine.2013.01.035. Epub 2013 Jan 29.

PMID:
23370149
8.

Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.

Briggs DJ, Banzhoff A, Nicolay U, Sirikwin S, Dumavibhat B, Tongswas S, Wasi C.

Bull World Health Organ. 2000;78(5):693-8.

9.

Purified chick embryo cell rabies vaccine: economical multisite intradermal regimen for post-exposure prophylaxis.

Suntharasamai P, Warrell MJ, Viravan C, Chanthavanich P, Looareesuwan S, Supapochana A, Supanaranond JK, Chittamas S, Bijok U, Warrell DA.

Epidemiol Infect. 1987 Dec;99(3):755-65.

10.

Immunogenicity of purified duck embryo rabies vaccine (Lyssavac-N) with use of the WHO-approved intradermal postexposure regimen.

Khawplod P, Glueck R, Wilde H, Tantawichien T, Chomchey P, Thipkong P, Benjavongkulchai M, Sumboonanondha A, Prakongsri S, Siakasem A, et al.

Clin Infect Dis. 1995 Mar;20(3):646-51.

PMID:
7756490
11.

[Efficacy of intradermal regimen using Japanese rabies vaccine for pre-exposure prophylaxis].

Shiota S, Ahmed K, Mifune K, Nishizono A.

Kansenshogaku Zasshi. 2010 Jan;84(1):9-13. Japanese.

PMID:
20170007
12.
13.

Comparison of saftey and immunogenicity of purified chick embryo cell rabies vaccine (PCECV) and purified vero cell rabies vaccine (PVRV) using the Thai Red Cross intradermal regimen at a dose of 0.1 ML.

Madhusudana SN, Sanjay TV, Mahendra BJ, Sudarshan MK, Narayana DH, Giri A, Muhamuda K, Ravi V, Vakil HB, Malerczyk C.

Hum Vaccin. 2006 Sep-Oct;2(5):200-4.

PMID:
17035734
14.

Safety and immunogenicity study of a new purified chick embryo cell rabies vaccine Vaxirab-N (Pitman-Moore strain) manufactured in India.

Ashwath Narayana DH, Madhusudana SN, Sampath G, Tripathy RM, Sudarshan MK, Gangaboraiah, Ravish HS, Satapathy DM, Gowda G, Holla R, Ashwin BY, Padhi A, Manjula S, Patel PM.

Hum Vaccin Immunother. 2014;10(1):120-5. doi: 10.4161/hv.26456. Epub 2013 Sep 12.

15.

Protecting Indian schoolchildren against rabies: pre-exposure vaccination with purified chick embryo cell vaccine (PCECV) or purified verocell rabies vaccine (PVRV).

Shanbag P, Shah N, Kulkarni M, Juvekar M, Madhusudana SN, Vakil HB, Malerczyk C.

Hum Vaccin. 2008 Sep-Oct;4(5):365-9. Epub 2008 Oct 1.

PMID:
18398307
16.
17.

A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children, concomitantly with Japanese encephalitis vaccine.

Pengsaa K, Limkittikul K, Sabchareon A, Ariyasriwatana C, Chanthavanich P, Attanath P, Malerczyk C.

Pediatr Infect Dis J. 2009 Apr;28(4):335-7. doi: 10.1097/INF.0b013e3181906351.

PMID:
19333080
18.

Immunogenicity of rabies postexposure booster injections in subjects who had previously received intradermal preexposure vaccination.

Jaijaroensup W, Limusanno S, Khawplod P, Serikul K, Chomchay P, Kaewchomphoo W, Tantawichien T, Wilde H.

J Travel Med. 1999 Dec;6(4):234-7.

19.

Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: results of a randomized, open label, active-controlled trial in healthy adult volunteers in India.

Sudarshan MK, Narayana DH, Madhusudana SN, Holla R, Ashwin BY, Gangaboraiah B, Ravish HS.

Hum Vaccin Immunother. 2012 Aug;8(8):1077-81. doi: 10.4161/hv.20471. Epub 2012 Aug 1.

20.

Reduced dose pre-exposure primary and booster intradermal rabies vaccination with a purified chick embryo cell vaccine (PCECV) is immunogenic and safe in adults.

Roukens AH, Vossen AC, van Dissel JT, Visser LG.

Vaccine. 2008 Jun 25;26(27-28):3438-42. doi: 10.1016/j.vaccine.2008.04.033. Epub 2008 May 5.

PMID:
18511158
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk